These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 1360230

  • 1. c-erbB2 amplification and overexpression in human tumors.
    Lofts FJ, Gullick WJ.
    Cancer Treat Res; 1992; 61():161-79. PubMed ID: 1360230
    [Abstract] [Full Text] [Related]

  • 2. Regulation of expression and transforming ability of the c-erbB-2 gene.
    Matsuda S, Akiyama T, Yamada Y, Ishii S, Aizawa S, Mori S, Toyoshima K, Yamamoto T.
    Princess Takamatsu Symp; 1989; 20():93-101. PubMed ID: 2577338
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Clinical and pathologic significance of the c-erbB-2 (HER-2/neu) oncogene.
    Singleton TP, Strickler JG.
    Pathol Annu; 1992; 27 Pt 1():165-90. PubMed ID: 1346551
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Mechanisms of c-erbB2/neu oncogene-induced metastasis and repression of metastatic properties by adenovirus 5 E1A gene products.
    Yu D, Hamada J, Zhang H, Nicolson GL, Hung MC.
    Oncogene; 1992 Nov; 7(11):2263-70. PubMed ID: 1359495
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Expression of ERBB2 in human gastric carcinomas: relationship between p185ERBB2 expression and the gene amplification.
    Kameda T, Yasui W, Yoshida K, Tsujino T, Nakayama H, Ito M, Ito H, Tahara E.
    Cancer Res; 1990 Dec 15; 50(24):8002-9. PubMed ID: 1979253
    [Abstract] [Full Text] [Related]

  • 10. Mechanisms involving an expanding erbB/EGF receptor family of tyrosine kinases in human neoplasia.
    Di Fiore PP, Kraus MH.
    Cancer Treat Res; 1992 Dec 15; 61():139-60. PubMed ID: 1360229
    [No Abstract] [Full Text] [Related]

  • 11. Neu and its ligands: from an oncogene to neural factors.
    Peles E, Yarden Y.
    Bioessays; 1993 Dec 15; 15(12):815-24. PubMed ID: 7908191
    [Abstract] [Full Text] [Related]

  • 12. Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development.
    Kiguchi K, Bol D, Carbajal S, Beltrán L, Moats S, Chan K, Jorcano J, DiGiovanni J.
    Oncogene; 2000 Aug 31; 19(37):4243-54. PubMed ID: 10980598
    [Abstract] [Full Text] [Related]

  • 13. Amplification and overexpression of the dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 (DYRK2) gene in esophageal and lung adenocarcinomas.
    Miller CT, Aggarwal S, Lin TK, Dagenais SL, Contreras JI, Orringer MB, Glover TW, Beer DG, Lin L.
    Cancer Res; 2003 Jul 15; 63(14):4136-43. PubMed ID: 12874018
    [Abstract] [Full Text] [Related]

  • 14. Role of protein-tyrosine kinases in cellular transformation.
    Varticovski L.
    Sangre (Barc); 1991 Aug 15; 36(4):305-9. PubMed ID: 1663662
    [No Abstract] [Full Text] [Related]

  • 15. Involvement of tyrosine phosphorylation of p185(c-erbB2/neu) in tumorigenicity induced by X-rays and the neu oncogene in human breast epithelial cells.
    Kang KS, Sun W, Nomata K, Morita I, Cruz A, Liu CJ, Trosko JE, Chang CC.
    Mol Carcinog; 1998 Apr 15; 21(4):225-33. PubMed ID: 9585252
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of p185c-erbB-2 proto-oncogene expression by antisense oligodeoxynucleotides down-regulates p185-associated tyrosine-kinase activity and strongly inhibits mammary tumor-cell proliferation.
    Brysch W, Magal E, Louis JC, Kunst M, Klinger I, Schlingensiepen R, Schlingensiepen KH.
    Cancer Gene Ther; 1994 Jun 15; 1(2):99-105. PubMed ID: 7621247
    [Abstract] [Full Text] [Related]

  • 17. Collagen-induced morphogenesis and expression of the alpha 2-integrin subunit is inhibited in c-erbB2-transfected human mammary epithelial cells.
    D'Souza B, Berdichevsky F, Kyprianou N, Taylor-Papadimitriou J.
    Oncogene; 1993 Jul 15; 8(7):1797-806. PubMed ID: 8099725
    [Abstract] [Full Text] [Related]

  • 18. Expression of c-erbB family gene products in adenoid cystic carcinoma of salivary glands: an immunohistochemical study.
    Shintani S, Funayama T, Yoshihama Y, Alcalde RE, Ootsuki K, Terakado N, Matsumura T.
    Anticancer Res; 1995 Jul 15; 15(6B):2623-6. PubMed ID: 8669836
    [Abstract] [Full Text] [Related]

  • 19. Reduction of erbB2 gene product in mamma carcinoma cell lines by erbB2 mRNA-specific and tyrosine kinase consensus phosphorothioate antisense oligonucleotides.
    Bertram J, Killian M, Brysch W, Schlingensiepen KH, Kneba M.
    Biochem Biophys Res Commun; 1994 Apr 15; 200(1):661-7. PubMed ID: 7909438
    [Abstract] [Full Text] [Related]

  • 20. Overexpression of erbB-2 or EGF receptor proteins present in early stage mammary carcinoma is detected simultaneously in matched primary tumors and regional metastases.
    Lacroix H, Iglehart JD, Skinner MA, Kraus MH.
    Oncogene; 1989 Feb 15; 4(2):145-51. PubMed ID: 2564657
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.